Inflammatory dysregulation of vaccine responses in sickle cell disease
镰状细胞病疫苗反应的炎症失调
基本信息
- 批准号:10617772
- 负责人:
- 金额:$ 47.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-12 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAdjuvantAffectAfrican American populationAgeAgingAmino Acid SubstitutionAntibodiesAppearanceB-LymphocytesBiological AssayBlood PlateletsBlood specimenBone necrosisCell LineageCellsCellular Indexing of Transcriptomes and Epitopes by SequencingChronicClinicalDataData AnalysesData SetDevelopmentEnzyme-Linked Immunosorbent AssayErythrocyte MembraneFrequenciesFunctional disorderGene ExpressionGeneticGenetic TranscriptionHematological DiseaseHemeHemolysisHydrophobicityImmuneImmune responseImmunityImmunoglobulin AImmunoglobulin MImmunologic MarkersImmunologic StimulationImmunologicsImpairmentIn SituIncomeInfectionInflammasomeInflammatoryInvestigationIronIschemiaLife ExpectancyLigandsMF59Mass Spectrum AnalysisMemory B-LymphocyteMicrocirculationModalityModelingMolecular ProfilingNatural ImmunityOrganPainPathway interactionsPatientsPattern recognition receptorPeripheral Blood Mononuclear CellPhenotypePoint MutationPolyvalent pneumococcal vaccinePredispositionProductionProteomicsPulmonary HypertensionRecurrenceRetinal DiseasesSerotypingSerum ProteinsSeverity of illnessShapesSickle CellSickle Cell AnemiaSkinStreptococcus pneumoniaeStrokeSystemT cell responseT-Lymphocyte SubsetsTLR4 geneTherapeuticTransfusionUnited StatesVaccinationVaccinesVulnerable PopulationsWhole Bloodadaptive immunitybeta Globincytokinedata managementfluglobal healthhemoglobin polymerhydroxyureaimmunological statusimprovedinflammatory milieuinfluenza virus vaccinelymph node biopsyneutrophilpatient populationprotein biomarkersresponders and non-respondersresponseseroconversionsicklingsingle cell technologytranscriptomicsvaccination strategyvaccine efficacyvaccine responsevascular abnormality
项目摘要
Abstract
Sickle cell disease (sickle cell) is the most common genetic hematologic disorder in the United States and an
increasing global health problem. Sickle cell patients have a range of acute and chronic multisystem clinical
complications and considerably shortened life expectancy. Paradoxically, despite their hyperinflammatory state,
sickle cell patients have reduced responses to vaccination, suggesting dysregulation or impairments in immune
pathways reminiscent of our studies of the chronic inflammatory milieu in aging. A broad investigation of the
systemic immune response in patients with sickle cell disease is necessary for the understanding of whether
chronic hyperinflammatory immune status may contribute to increased susceptibility to infections and reduced
responses to vaccines in this vulnerable population. We will employ recent advances in single-cell technologies
to quantify and analyze sickle cell disease patient immune status and responses to vaccinations. Our study will
provide in-depth multiparameter immune profiles and analysis to identify molecular signatures defining the
hyperinflammatory state and reduced vaccine efficacy in sickle cell disease patient populations.
摘要
镰状细胞病(镰状细胞)是美国最常见的遗传性血液病,
日益严重的全球健康问题。镰状细胞病患者具有一系列急性和慢性多系统临床
并发症和预期寿命大大缩短。奇怪的是,尽管他们处于高度炎症状态,
镰状细胞患者对疫苗接种的反应降低,表明免疫调节失调或受损,
这让人想起我们对衰老过程中慢性炎症环境的研究。一个广泛的调查
镰状细胞病患者的全身免疫应答对于了解是否
慢性炎症性免疫状态可能导致对感染的易感性增加,
疫苗接种在这个脆弱的群体。我们将利用单细胞技术的最新进展
量化和分析镰状细胞病患者的免疫状态和对疫苗接种的反应。我们的研究将
提供深入的多参数免疫概况和分析,以确定定义免疫缺陷的分子特征。
在镰状细胞病患者群体中的高炎症状态和降低的疫苗效力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUTH R MONTGOMERY其他文献
RUTH R MONTGOMERY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUTH R MONTGOMERY', 18)}}的其他基金
Project 2: Molecular Signatures of West Nile virus susceptibility
项目 2:西尼罗河病毒易感性的分子特征
- 批准号:
10317021 - 财政年份:2020
- 资助金额:
$ 47.86万 - 项目类别:
Inflammatory dysregulation of vaccine responses in sickle cell disease
镰状细胞病疫苗反应的炎症失调
- 批准号:
10420328 - 财政年份:2010
- 资助金额:
$ 47.86万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 47.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 47.86万 - 项目类别:
Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 47.86万 - 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 47.86万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 47.86万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 47.86万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 47.86万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 47.86万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 47.86万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 47.86万 - 项目类别:














{{item.name}}会员




